Skip to Main Content (Press Enter)

Logo UNISR
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills

UNIFIND
Logo UNISR

|

UNIFIND

unisr.it
  • ×
  • Home
  • People
  • Outputs
  • Organizations
  • Expertise & Skills
  1. Outputs

The impact of 2023 EMA recommendations on patients treated with JAK inhibitors: real-life experience from a prospective monocentric cohort

Academic Article
Publication Date:
2024
Short description:
The impact of 2023 EMA recommendations on patients treated with JAK inhibitors: real-life experience from a prospective monocentric cohort / Tomelleri, A., Benanti, G., Cariddi, A., Calvisi, S.L., Baldissera, E., Boffini, N., Matucci Cerinic, M., Dagna, L.. - In: RHEUMATOLOGY. - ISSN 1462-0324. - 63:2(2024), pp. 39-42. [10.1093/rheumatology/kead395]
Iris type:
1.1.2. Articolo in Rivista - Letter, Note
List of contributors:
Tomelleri, A.; Benanti, G.; Cariddi, A.; Calvisi, S. L.; Baldissera, E.; Boffini, N.; Matucci Cerinic, M.; Dagna, L.
Authors of the University:
DAGNA LORENZO
MATUCCI CERINIC MARCO
Handle:
https://iris.unisr.it/handle/20.500.11768/184740
Full Text:
https://iris.unisr.it//retrieve/handle/20.500.11768/184740/304502/The%20impact%20of%202023%20EMA%20recommendations%20on%20patients.pdf
Published in:
RHEUMATOLOGY
Journal
  • Use of cookies

Powered by VIVO | Designed by Cineca | 26.5.2.0